Precision Peptide Company Total Current Liabilities

Precision Peptide Company (BPC.CN) currently reports a total current liabilities of $430K as of July 2026. That compares with $300K in the prior-year period — up 42.2% year over year. Use the charts on this page to explore Precision Peptide Company's total current liabilities history and peer comparisons.

Precision Peptide Company's total current liabilities increased from $300K to $430K — a 42.2% year-over-year increase (period ending July 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Precision Peptide Company reported $430K in total current liabilities as of July 2026. That compares with $300K in the prior-year period — up 42.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $430K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Precision Peptide Company, and consider following BPC.CN for alerts when major investors trade the stock.